Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T17:34:07.036Z.
Calculation as of: 2026-10-06T17:34:07.036Z.
Quote observation: 2026-10-06T17:27:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a4f1da35868143a3e9cc9e15baeeae426ebbcf8636af82277700bcf7ee6cbb8a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$78.07M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.31M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.37M
Price/FCF Ratio
4.59
TTM Avg
5.17
3Y Avg
25.10
5Y Avg
25.10
Market Cap
$79.96M
Price/FCF Ratio
N/A
TTM Avg
786.60
3Y Avg
786.60
5Y Avg
786.60
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $77.53M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $77.08M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.37M | 4.59 | 5.17 | 25.10 | 25.10 |
| Hyperfine, Inc. (HYPR)vs › | $76.64M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $75.35M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | N/A | 786.60 | 786.60 | 786.60 |
| Nutriband Inc. (NTRB)vs › | $80.11M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
